Logo image of ALMKS.PA

MAKING SCIENCE GROUP SA (ALMKS.PA) Stock Fundamental Analysis

EPA:ALMKS - Euronext Paris - Matif - ES0105463006 - Common Stock - Currency: EUR

8.75  +0.15 (+1.74%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALMKS. ALMKS was compared to 67 industry peers in the Media industry. ALMKS has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKS is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALMKS had positive earnings in the past year.
ALMKS had a positive operating cash flow in the past year.
In multiple years ALMKS reported negative net income over the last 5 years.
In multiple years ALMKS reported negative operating cash flow during the last 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

With a Return On Assets value of 0.39%, ALMKS perfoms like the industry average, outperforming 41.79% of the companies in the same industry.
ALMKS has a Return On Equity (3.25%) which is in line with its industry peers.
The Return On Invested Capital of ALMKS (9.78%) is better than 82.09% of its industry peers.
Industry RankSector Rank
ROA 0.39%
ROE 3.25%
ROIC 9.78%
ROA(3y)-3.19%
ROA(5y)-0.63%
ROE(3y)-30.41%
ROE(5y)27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 0.25%, ALMKS is in line with its industry, outperforming 40.30% of the companies in the same industry.
The Operating Margin of ALMKS (3.03%) is comparable to the rest of the industry.
ALMKS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 22.07%, ALMKS is doing worse than 80.60% of the companies in the same industry.
ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.03%
PM (TTM) 0.25%
GM 22.07%
OM growth 3Y-49.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.87%
GM growth 5YN/A
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
The number of shares outstanding for ALMKS has been increased compared to 1 year ago.
Compared to 1 year ago, ALMKS has a worse debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

ALMKS has an Altman-Z score of 1.72. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALMKS (1.72) is comparable to the rest of the industry.
ALMKS has a debt to FCF ratio of 4.69. This is a neutral value as ALMKS would need 4.69 years to pay back of all of its debts.
ALMKS's Debt to FCF ratio of 4.69 is fine compared to the rest of the industry. ALMKS outperforms 62.69% of its industry peers.
ALMKS has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
ALMKS's Debt to Equity ratio of 1.50 is on the low side compared to the rest of the industry. ALMKS is outperformed by 64.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 4.69
Altman-Z 1.72
ROIC/WACC1.37
WACC7.15%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.74 indicates that ALMKS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.74, ALMKS is doing worse than 67.16% of the companies in the same industry.
ALMKS has a Quick Ratio of 0.74. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKS's Quick ratio of 0.71 is on the low side compared to the rest of the industry. ALMKS is outperformed by 65.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.71
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.31%, which is quite impressive.
Looking at the last year, ALMKS shows a quite strong growth in Revenue. The Revenue has grown by 9.46% in the last year.
ALMKS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.87% yearly.
EPS 1Y (TTM)106.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.35%
Revenue 1Y (TTM)9.46%
Revenue growth 3Y59.87%
Revenue growth 5YN/A
Sales Q2Q%10.63%

3.2 Future

ALMKS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 114.64% yearly.
Based on estimates for the next years, ALMKS will show a quite strong growth in Revenue. The Revenue will grow by 10.42% on average per year.
EPS Next Y266.67%
EPS Next 2Y174.87%
EPS Next 3Y114.64%
EPS Next 5YN/A
Revenue Next Year8.43%
Revenue Next 2Y11.37%
Revenue Next 3Y10.42%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 145.83, ALMKS can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ALMKS is valued a bit more expensive than the industry average as 62.69% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 29.35. ALMKS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 12.62 indicates a correct valuation of ALMKS.
ALMKS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ALMKS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 145.83
Fwd PE 12.62
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

ALMKS's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ALMKS is valued a bit cheaper than 76.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.76
EV/EBITDA 10.17
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKS's earnings are expected to grow with 114.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y174.87%
EPS Next 3Y114.64%

More info and screens

0

5. Dividend

5.1 Amount

ALMKS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAKING SCIENCE GROUP SA

EPA:ALMKS (3/7/2025, 7:00:00 PM)

8.75

+0.15 (+1.74%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners69.07%
Ins Owner ChangeN/A
Market Cap78.58M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-44.07%
EPS NY rev (3m)-44.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.29%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE 145.83
Fwd PE 12.62
P/S 0.32
P/FCF 5.76
P/OCF 5.46
P/B 4.13
P/tB N/A
EV/EBITDA 10.17
EPS(TTM)0.06
EY0.69%
EPS(NY)0.69
Fwd EY7.93%
FCF(TTM)1.52
FCFY17.37%
OCF(TTM)1.6
OCFY18.31%
SpS27.6
BVpS2.12
TBVpS-5.13
PEG (NY)0.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.39%
ROE 3.25%
ROCE 14.11%
ROIC 9.78%
ROICexc 17.03%
ROICexgc N/A
OM 3.03%
PM (TTM) 0.25%
GM 22.07%
FCFM 5.51%
ROA(3y)-3.19%
ROA(5y)-0.63%
ROE(3y)-30.41%
ROE(5y)27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.87%
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 4.69
Debt/EBITDA 2.56
Cap/Depr 20.14%
Cap/Sales 0.3%
Interest Coverage 1.39
Cash Conversion 128.77%
Profit Quality 2212.61%
Current Ratio 0.74
Quick Ratio 0.71
Altman-Z 1.72
F-Score5
WACC7.15%
ROIC/WACC1.37
Cap/Depr(3y)269.23%
Cap/Depr(5y)362.44%
Cap/Sales(3y)9.24%
Cap/Sales(5y)8.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.35%
EPS Next Y266.67%
EPS Next 2Y174.87%
EPS Next 3Y114.64%
EPS Next 5YN/A
Revenue 1Y (TTM)9.46%
Revenue growth 3Y59.87%
Revenue growth 5YN/A
Sales Q2Q%10.63%
Revenue Next Year8.43%
Revenue Next 2Y11.37%
Revenue Next 3Y10.42%
Revenue Next 5YN/A
EBIT growth 1Y383.07%
EBIT growth 3Y-19.64%
EBIT growth 5YN/A
EBIT Next Year554.17%
EBIT Next 3Y107.69%
EBIT Next 5YN/A
FCF growth 1Y261.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y373.2%
OCF growth 3YN/A
OCF growth 5YN/A